Home > Blog

Blog | Veristat

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Sign Up Today

Clinical Trials

4 min read

Early Detection vs. Overdiagnosis: The ctDNA Screening Paradox

The promise of circulating tumor DNA for early cancer detection comes with a complex paradox: the very sensitivity that makes ctDNA valuable for catching cancer early also raises concerns about overdiagnosis and overtreatment. As Dr. Gabriela Rosu,...

READ MORE

1 min read

Accelerate Neurology/Psychiatry Trial Success with Expert Guidance

Learn how our neuroscience team partner with sponsors across multiple therapeutic areas to accelerate trial success in complex neurological and psychiatric conditions. Our collaborative efforts have supported successful marketing applications,...

READ MORE

3 min read

Beyond Detection: How ctDNA Could Optimize Treatment Selection

The promise of circulating tumor DNA (ctDNA) extends far beyond simply detecting cancer; it also holds potential for personalized treatment. As Dr. Gabriela Rosu, Veristat’s Vice President, Global Medical Affairs, recently explained, "If we know that...

READ MORE

1 min read

Accelerating Patient-Centric Trials: A Sponsor Checklist for Science-Based Planning

Learn how our patient-centric approach helps sponsors streamline development and reduce trial burden without compromising rigor. Our collaborative efforts led to improved enrollment timelines, enhanced patient engagement, and accelerated submission...

READ MORE

3 min read

FSP/Resourcing: Meeting the Moment with Expert Resources

Clinical trial leaders in small and medium-sized biotech companies regularly find themselves at the intersection of growing requirements, shrinking timelines, and talent shortages. With organizational restructuring and staffing reductions continuing,...

READ MORE

1 min read

Exploring Future Trends on European Regulations: A Webinar by Veristat and TOPRA

Veristat, in partnership with TOPRA, recently hosted an insightful webinar titled "Future Trends on European Regulations on Medicines." This webinar provided valuable updates on the new Pharmaceutical Strategy for Europe and its impact on the regulatory...

READ MORE

1 min read

Unlocking Insights: The Impact of New Medical Device EU Regulation (MDR)

Veristat and TOPRA recently hosted an informative webinar on the topic of the impact of new EU regulations on the development of medical devices and drug combination products. The European Commission's adoption of Regulation (EU)

READ MORE

2 min read

On-Demand Webinar: Single-Arm Studies for Use as a Registrational Study in Oncology

Single-arm clinical trials are gaining attention as potential registrational studies in oncology research. This webinar provides an overview of single-arm trials, their foundations for registration, and regulatory strategies associated with the US...
READ MORE

1 min read

The Rise of Decentralized Clinical Trials: Transforming Research Through Technology and Patient-Centricity

Learn how decentralized clinical trials (DCTs) are reshaping the clinical research landscape. Explore the insights shared by Shaheen Limbada, EVP of Innovation and Strategy at Veristat as he discusses the lessons learned from the pandemic, the role of...

READ MORE

4 min read

Weighing the Suitability of a Functional Service Provider (FSP) Model for Clinical Trials

Clinical and regulatory teams face increased pressure to drive uninterrupted progress across the clinical development pathway. These teams routinely benefit from the support of an external partner who can minimize the risks of failure and missed...

READ MORE